1984
DOI: 10.1016/s0140-6736(84)91057-2
|View full text |Cite
|
Sign up to set email alerts
|

Symptoms After Primary Immunisation With DTP and With Dt Vaccine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
14
0
3

Year Published

1989
1989
2016
2016

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 54 publications
(18 citation statements)
references
References 0 publications
1
14
0
3
Order By: Relevance
“…Despite the small size of our study, the absolute risks of a convulsion after a third dose of DTP vaccine of 1 in 9800 approximately, and of a convulsion 6-11 days after MMR vaccine of 1 in 2850 (matched admissions only) were consistent with other estimates [2]. The absence of admissions for collapse, which have been reported after American DTP vaccines in association with pyrexia [5], is consistent with an earlier study of British DTP vaccine in which recipients were actively followed up after each dose [6].…”
Section: Discussionsupporting
confidence: 88%
“…Despite the small size of our study, the absolute risks of a convulsion after a third dose of DTP vaccine of 1 in 9800 approximately, and of a convulsion 6-11 days after MMR vaccine of 1 in 2850 (matched admissions only) were consistent with other estimates [2]. The absence of admissions for collapse, which have been reported after American DTP vaccines in association with pyrexia [5], is consistent with an earlier study of British DTP vaccine in which recipients were actively followed up after each dose [6].…”
Section: Discussionsupporting
confidence: 88%
“…The Hib vaccine is unlikely to have contributed substantially to higher rates for the last dose of the acellular combination as reactions to a third dose of PRP-T are uncommon in this schedule [4,11]. Diphtheria or tetanus toxoids may play a part in local reactions to DTaP vaccines [29,37]. Alternatively, reactions may derive from an immunological response to PT or FHA [20,27] or from vaccine adjuvants or preservatives.…”
Section: Discussionmentioning
confidence: 99%
“…Inactivated whole-cell vaccines (WCVs) have been used for more than 30 years and have successfully reduced the incidence of pertussis (11). However, some adverse side effects have been associated with the administration of WCVs (30), and these have led to development of new, acellular vaccines (ACVs). The safety and reduced reactogenicity of ACVs compared to WCVs have been well established by their extensive use in Japan (15) and by several clinical trials (7,10).…”
mentioning
confidence: 99%